New blood test may spot liver cancer earlier in hepatitis c patients

NCT ID NCT07404566

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether measuring tiny molecules called microRNAs in the blood can help diagnose liver cancer (hepatocellular carcinoma) in people with hepatitis C. Researchers tested blood samples from 84 participants, including healthy people and those with hepatitis C, with or without liver cancer. They measured five specific microRNAs to see if they could accurately tell apart liver cancer from other liver conditions. The goal is to develop a more reliable screening tool than current blood tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
PCR measurement of microRNA levels (MiR-21, 1246, 205, 29a-3p, 497) in blood
What this could lead to
If successful, this could lead to a simple blood test that detects liver cancer earlier and more accurately in people with hepatitis C.
What could go wrong
This is a small, completed study with 84 participants, so results may not apply to larger or different groups. The test is still experimental and not yet ready for routine use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATITIS C VIRUS INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Alexandria Faculty of medicine

    Alexandria, El Alexandria, 21512, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.